MTMR2 inhibits the signaling cascade, suppressing IRF-1 expression, relieving the inhibitory effects of IRF-1 on ZEB1, and facilitating epithelial-mesenchymal transition in tumor cells. The gene discussed is ZEB1; the disease is neoplasm.